• Duphat
  • infinia camp
mededge mea logo web MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Reading: WHO Validates Pakistan’s Elimination of Trachoma
Share
Notification
  • Duphat
  • infinia camp
mededge mea logo web
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Have an existing account? Sign In
MedEdge MEA > News > WHO Validates Pakistan’s Elimination of Trachoma
News

WHO Validates Pakistan’s Elimination of Trachoma

ME Desk
ME Desk
Published: October 2, 2024
Share
3 Min Read
WHO Validates Pakistan’s Elimination of Trachoma
SHARE

01 October 2024- In a monumental achievement for public health, the World Health Organization (WHO) has validated the elimination of trachoma as a public health problem in Pakistan. Trachoma is a disease caused by infection by the Chlamydia trachomatis bacterium and can result in irreversible blindness if left untreated.

Pakistan has become the 19th country globally to reach this historic milestone. Its success underscores the Government of Pakistan’s political commitment to public health, the value of WHO technical support and the incredible contributions of health professionals, endemic communities, civil society and partners like Sightsavers, Christian Blind Mission and the Fred Hollows Foundation. The achievement is a significant marker in the global fight against preventable diseases and their elimination.

In 1997, Pakistan eradicated Guinea worm disease. Moreover, elimination of trachoma as a public health problem adds to this legacy. This latest success is not the end but a precursor to more milestone achievements along the road.

Also Read: Jordan becomes first country to receive WHO verification for eliminating leprosy

As Pakistan’s Prime Minister Shehbaz Sharif stated: “Today marks a pivotal moment in our journey towards a healthier Pakistan. Together with our partners, we not only celebrate this achievement but reaffirm our unwavering commitment to effectively control and eliminate diseases impeding our socioeconomic development by placing quality health care within the reach of everyone in Pakistan.”

“Elimination of trachoma as a public health problem in Pakistan is a monumental achievement for the country and for the global fight against the disease,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.

Regional Director for the Eastern Mediterranean Dr Hanan Balkhy underlined the significance of the achievement: “Congratulations to Pakistan on the elimination of trachoma! Now Pakistan has eliminated two neglected tropical diseases, demonstrating the country’s dedication to public health and serving as an inspiration to all.”

“This is a remarkable achievement which will save thousands of people from preventable visual impairment or blindness,” said WHO Representative in Pakistan Dr Luo Dapeng.

Furthermore, Pakistan’s successful elimination of trachoma as a public health problem serves as a powerful reminder that the control, elimination and eradication of many neglected tropical diseases is an attainable goal.

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article Bristol Myers Squibb Collaborates for 4th Blood Donation Drive Bristol Myers Squibb Collaborates for 4th Blood Donation Drive in Dubai
Next Article Anthony Hilliard announced as acting CEO of LLUH hospitals Anthony Hilliard announced as acting CEO of LLUH hospitals

Recent Posts

  • From market access to national ambition, gulf healthcare is playing a longer game
  • New Push for HIV Innovation and Access Aims to Accelerate Progress Toward 2030 Goals
  • WHO Discusses Digital Health and Humanization of Care at Scientific Conference
  • Rising Ebola Cases Deepen Humanitarian Crisis for Children in DR Congo
  • Burjeel holdings secures dual credit ratings and launches USD 1.5 billion sukuk programme
  • duphat
  • MedEdge-Infinia
Two Point Five Logo white
  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: WHO Validates Pakistan’s Elimination of Trachoma
Share

Published by Two Point Five Media FZCO

  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: WHO Validates Pakistan’s Elimination of Trachoma
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?